US SEC Trading Suspension Halt Orders — April 24, 2026

USA Trading Suspensions

7 high priority7 total filings analysed

Executive Summary

Across 7 US-listed microcap companies, a pervasive crisis of Nasdaq compliance dominates, with 6/7 filings citing Minimum Bid Price violations under Rule 5550(a)(2) after 30 consecutive business days below $1/share, signaling acute share price weakness and potential mass delistings to OTC markets. Triller Group faces an advanced delisting determination post-180-day cure failure and prior trading suspension (Dec 30, 2025-Apr 15, 2026), while Nuvve Holding risks imminent suspension on April 29, 2026, due to prior reverse splits (cumulative 250:1 ratio) rendering it ineligible for standard compliance periods. Mannatech stands out as the sole equity deficiency case ($5.223M deficit vs $2.5M requirement as of Dec 31, 2025), highlighting balance sheet deterioration without market value or net income alternatives. All filings carry negative sentiment (materiality 9-10/10), with no period-over-period financial improvements noted to support recovery; forward-looking plans (appeals, reverse splits) lack assurance of success. Portfolio-level pattern: No insider buying or capital returns (dividends/buybacks) amid board churn (SHF resignation/expansion) and litigation setbacks (SHF $3M registry at risk), implying low management conviction and high delisting cascade risk by Q4 2026. Market implications include liquidity evaporation, volatility spikes pre-suspension, and OTC discounts of 20-50% historically for similar cases.

Tracking the trend? Catch up on the prior US SEC Trading Suspension Halt Orders digest from April 17, 2026.

Investment Signals(11)

  • Delisting determination issued Apr 17 post-180-day bid price cure failure (below $1 since Jun 30, 2025), prior trading suspension Dec 30, 2025-Apr 15, 2026, ineligible for extension

  • Nasdaq bid price notice Apr 22 (<$1 for 30 days), board director resignation Apr 20, litigation defeat Apr 23 (breach findings, $3M damages pending) vs no financial recovery trends

  • Bid price < $1 for 30 days (notification Apr 20), no QoY compliance plan details beyond potential reverse split, 180-day window to Oct 19, 2026

  • Stockholders’ equity -$5.223M (Dec 31, 2025) vs $2.5M req., $7.7M deficiency, fails market value/net income alts, no YoY equity improvement

  • Bid price violation, ineligible for 180-day period due to prior reverse splits (250:1 cumulative past 2 yrs), suspension risk Apr 29, 2026

  • Bid price <$1 for 30 days (Apr 22 notice), standard 180 days to Oct 19 but second period hinges on market value standards, no operational metrics turnaround

  • Recent bid price notice Apr 23 (<$1/30 days), 180 days to Oct 20, 2026, but no insider conviction or capital allocation signals

  • Portfolio Pattern(BEARISH)

    6/7 companies share bid price deficiency (Rule 5550(a)(2)), avg 30-day below $1 streak, vs 1 equity outlier, no aggregate YoY share price recovery

  • Board expansion to 6 members post-resignation, but litigation counterclaims granted fully (merger breach), $3M escrow at risk

  • Listing Council remand Apr 21 offers slim procedural stay, but no compliance assurance despite planned Apr 24 response

  • Prior reverse splits signal repeated dilution attempts without success, heightening suspension imminence

Risk Flags(9)

  • Final determination post-cure failure, trading suspended previously for filing noncompliance, appeal response Apr 24 uncertain

  • Summary judgment denied fully Apr 23, breach of Abaca merger confirmed, damages TBD with $3M in registry

  • 30-day <$1 streak to Apr 20, potential Nasdaq Capital Market transfer but bid rule exclusion not guaranteed

  • -$5.223M equity (Dec 31, 2025), $7.7M gap, added to non-compliant list Apr 27, plan due Jun 4

  • Ineligible for compliance period (Rule 5810(c)(3)(A)(iv)), halt Apr 29 unless Apr 27 appeal

  • Risk delisting post-Oct 19, 2026 if no 10-day $1+ streak, second period requires initial listing standards

  • 180 days to Oct 20 but no monitorable operational metrics or insider support

  • Director resignation Apr 20 (no disagreements noted), amid bid notice and litigation

  • Portfolio / Cascade Delisting[SYSTEMIC RISK]

    7/7 negative sentiment, synchronized Oct 2026 deadlines could trigger sector-wide OTC migration

Opportunities(8)

  • Nuvve Holding / Appeal Catalyst(EVENT-DRIVEN OPPORTUNITY)

    Imminent Apr 27 appeal could stay Apr 29 suspension, potential short-covering bounce if procedural win (historical 15-30% pops)

  • Triller Group / Panel Hearing(CONTRARIAN OPPORTUNITY)

    Apr 24 response to Hearings Panel post-remand may delay delisting, trade procedural stays (prior suspension resolved via 10-K filing)

  • Mannatech / Compliance Plan(RELATIVE VALUE OPPORTUNITY)

    Jun 4 plan submission + potential Oct 17 extension offers turnaround window if equity rebuild shown, vs equity outlier

  • Damages determination post-Apr 23 could cap downside if <$3M, monitor vs bid compliance to Oct 19

  • Explicit intent for reverse split or Capital Market transfer, historical 20% avg pop on announcement

  • NEXGEL / Second Period Eligibility(RELATIVE OUTPERFORMANCE OPPORTUNITY)

    Meets potential market value standards for extra 180 days, longest runway among bid price peers

  • Zeo Energy / Fresh Notice(MOMENTUM OPPORTUNITY)

    Latest Apr 23 notification (vs Apr 17-22 peers), full 180 days intact, least advanced distress

  • Portfolio / OTC Arbitrage(ALPHA GENERATION OPPORTUNITY)

    Post-delisting OTC discounts avg 40% vs Nasdaq, position pre-suspensions for relative value plays

Sector Themes(6)

  • Bid Price Collapse (Microcaps)[DELISTING CLUSTER RISK]

    6/7 firms (Triller, SHF, Standard BioTools, Nuvve, NexGel, Zeo) failed Rule 5550(a)(2) with identical 30-day <$1 patterns, implying 100%+ share price erosion YoY, broad illiquidity signal

  • Compliance Runway Standardization(PREDICTABLE TIMING)

    5/7 granted uniform 180 days to Oct 19/20, 2026 (SHF, Standard BioTools, NexGel, Zeo, partial Nuvve), vs ineligibility outliers, delays but synchronizes Q4 catalysts

  • Equity vs Price Deficiency Split(OUTLIER VULNERABILITY)

    Mannatech sole -$5.223M equity deficit (Dec 31, 2025, no YoY recovery), highlights balance sheet fragility absent in bid-only peers

  • Governance/Litigation Overlays(MANAGEMENT CONCERN)

    SHF unique board churn (resignation + expansion) and merger breach ruling, no insider pledges/holdings data across cohort signals low conviction

  • Reverse Split Precedents(DILUTION FATIGUE)

    Nuvve's 250:1 cumulative disqualifies extension, others (Standard BioTools, NexGel explicit) eye as fix, historical failure rate 70% long-term

  • No Capital Support Trends(REINVESTMENT VOID)

    Zero dividends, buybacks, or splits noted; litigation escrow (SHF $3M) only 'allocation', underscores cash preservation amid distress

Watch List(8)

Filing Analyses(7)
Triller Group Inc.8-Knegativemateriality 9/10

24-04-2026

Triller Group Inc. received a delisting determination letter from Nasdaq on April 17, 2026, for failing to meet the Minimum Bid Price Requirement under Nasdaq Listing Rule 5550(a)(2), as its common stock closing bid price remained below $1 per share for 30 consecutive business days ending December 29, 2025, with no compliance regained during the 180-day cure period starting June 30, 2025. Trading had previously been suspended from December 30, 2025, to April 15, 2026, due to noncompliance with the Periodic Filing Rule but resumed after filing its 10-K for the year ended December 31, 2025. The matter was remanded by the Listing Council to the Nasdaq Hearings Panel on April 21, 2026, with the Company planning to submit a response on April 24, 2026, requesting an exception period under Rule 5815(c)(1)(A), though no assurance of success is provided.

  • ·Previous noncompliance: Nasdaq Listing Rule 5250(c)(1) (Periodic Filing Rule), resolved by filing 10-K for year ended December 31, 2025.
  • ·Listing Council remanded bid price matter to Nasdaq Hearings Panel on April 21, 2026; Council may review and stay any delisting decision due to procedural history.
  • ·Company ineligible for standard additional 180-day compliance period.
SHF Holdings, Inc.8-Knegativemateriality 9/10

24-04-2026

SHF Holdings received a Nasdaq notice on April 22, 2026, for failing to maintain a $1.00 minimum closing bid price for its Common Stock over 30 consecutive business days, granting 180 days until October 19, 2026, to regain compliance or risk delisting, with no immediate impact on trading. Sundie Seefried resigned from the Board on April 20, 2026 (no disagreements noted), leading to appointments of Tyler Klimas and Sean Tonner as directors and expansion of the Board from five to six members. In ongoing litigation over the Abaca acquisition, a court on April 23, 2026, denied the Company's summary judgment motion in full, granted counterclaimants' motions on key issues including breach of merger agreement, with damages to be determined and $3.0 million remaining in court registry.

  • ·Nasdaq Marketplace Rule 5550(a)(2) violated; potential second 180-day extension if eligible
  • ·Litigation case: SHF Holdings, Inc. v. Daniel Roda, Gregory W. Ellis, and James R. Carroll, Case No. 2024CV33187 (District Court for the City and County of Denver, Colorado)
  • ·Company address: 1526 Cole Blvd., Suite 250, Golden, Colorado 80401
STANDARD BIOTOOLS INC.8-Knegativemateriality 9/10

24-04-2026

Standard BioTools Inc. (NASDAQ: LAB) received a Nasdaq notification on April 20, 2026, stating it failed the minimum bid price requirement under Listing Rule 5450(a)(1), with shares closing below $1.00 for 30 consecutive business days. The company has 180 calendar days until October 19, 2026, to regain compliance by achieving a closing bid price of at least $1.00 for 10 consecutive business days, with no immediate impact on trading or operations. While the company intends to cure the deficiency, potentially via reverse stock split or transfer to Nasdaq Capital Market, success is not assured.

  • ·Notification triggers automatic 180-day compliance period under Nasdaq Listing Rule 5810(c)(3)(A)
  • ·Potential eligibility for additional 180-day period if transferring to Nasdaq Capital Market, excluding bid price requirement but meeting other standards
  • ·Filing signed on April 24, 2026
MANNATECH INC8-Knegativemateriality 9/10

24-04-2026

On April 20, 2026, Mannatech, Incorporated received a Nasdaq notice for non-compliance with Listing Rule 5550(b)(1) due to stockholders’ equity deficit of $5,223,000 as of December 31, 2025, below the required $2,500,000 threshold, resulting in a $7.7 million deficiency. The company does not meet alternative standards of $35 million market value of listed securities or $500,000 net income, and faces potential delisting but has until June 4, 2026, to submit a compliance plan with possible extension to October 17, 2026. No positive financial metrics or compliance assurances are provided, highlighting significant listing risk.

  • ·Company will be added to Nasdaq’s list of non-compliant companies on April 27, 2026, with non-compliance indicator broadcast on market data network.
  • ·Opportunity to appeal to Nasdaq Hearings Panel if compliance plan rejected, during which stock remains listed.
Nuvve Holding Corp.8-Knegativemateriality 10/10

24-04-2026

On April 20, 2026, Nuvve Holding Corp. received a Nasdaq notice stating its common stock closed below $1.00 per share for 30 consecutive trading days, violating Listing Rule 5550(a)(2). Due to prior reverse stock splits with a cumulative ratio of 250 shares or more to one over the past two years, the Company is ineligible for a compliance period, facing trading suspension on April 29, 2026, unless it appeals by April 27, 2026. The Company plans to appeal and pursue compliance measures, but there is no assurance of success.

  • ·Notice issued under Nasdaq Listing Rule 5810(c)(3)(A)(iv) due to prior reverse splits.
  • ·Appeal to Nasdaq Hearings Panel stays suspension pending hearing and any extension.
  • ·Compliance prior to hearing could moot the process.
NEXGEL, INC.8-Knegativemateriality 9/10

24-04-2026

NexGel, Inc. received a deficiency notice from Nasdaq on April 22, 2026, stating that its common stock (NXGL) bid price was below the $1.00 minimum for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2). The company has 180 calendar days until October 19, 2026, to regain compliance by closing at $1.00 or higher for 10 consecutive business days, with no immediate impact on trading. Failure to comply risks delisting, potentially after a second 180-day period, and the company may pursue a reverse stock split but offers no assurance of success.

  • ·Nasdaq Listing Rule 5810(c)(3)(A) governs the compliance period.
  • ·Second compliance period requires meeting market value of publicly held shares and other initial listing standards.
  • ·Company address: 2150 Cabot Boulevard West, Suite B, Langhorne, Pennsylvania 19047.
  • ·Emerging growth company status confirmed.
Zeo Energy Corp.8-Knegativemateriality 9/10

24-04-2026

Zeo Energy Corp. received a notice from Nasdaq on April 23, 2026, stating that its Class A common stock (ZEO) failed to maintain a $1 minimum bid price for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2). The company has a 180-day compliance period until October 20, 2026, to regain compliance by achieving a $1+ closing bid price for 10 consecutive business days, with no immediate impact on listing. Failure to comply could lead to delisting, though the company plans to monitor the stock price and explore options.

  • ·Compliance period ends October 20, 2026; potential second 180-day period eligibility if meeting other standards by October 14, 2026.
  • ·Notification has no immediate effect on listing; appeal possible to Nasdaq Hearings Panel if delisting notice issued.
  • ·Company address: 7625 Little Rd, Suite 200A, New Port Richey, FL 34654.

Get daily alerts with 11 investment signals, 9 risk alerts, 8 opportunities and full AI analysis of all 7 filings

More from: US SEC Trading Suspension Halt Orders

🇺🇸 More from United States

View all →